Takeda Bets on China for Global Growth 

(Bloomberg) -- Takeda Pharmaceutical Co. sees China becoming a “core country” for its global growth strategy and is optimistic its $62 billion acquisition of Shire Plc will win approval by the coun...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.